Improving health behaviors and outcomes after angioplasty: using economic theory to inform intervention.

Patients who have been relieved of cardiac symptoms following angioplasty may not be sufficiently motivated to initiate behavior changes that can reduce risk of subsequent cardiac events. Finding an effective means to help patients modify their behavior thus presents a unique challenge. This paper describes an innovative behavioral intervention whose theoretical underpinning is net-present value economic theory. This intervention is being evaluated in a randomized controlled trial in which all patients complete a computerized baseline health assessment of 14 cardiovascular risk factors. Each patient is presented with an individualized risk-factor profile and asked to choose risk factors for modification. In the experimental group, each risk factor is presented with a corresponding numerical biologic age value that represents the relative potential to benefit from modifying each risk factor. Risk reduction for these patients is framed as the opportunity to reduce present biologic age (the net-present value), and improve current health status and quality of life. In the control group, risk reduction is framed in the standard risk-factor approach as the value of preventing future health problems. We hope to demonstrate that economic theory is a plausible perspective from which to design interventions aimed at communicating risk and facilitating change in health behaviors.

[1]  M F Roizen,et al.  Better health while you wait: a controlled trial of a computer-based intervention for screening and health promotion in the emergency department. , 2001, Annals of emergency medicine.

[2]  J. Neal RealAge. Are You as Young as You Can Be , 2000 .

[3]  C. Gentz Perceived learning needs of the patient undergoing coronary angioplasty: an integrative review of the literature. , 2000, Heart & lung : the journal of critical care.

[4]  R. A. Trevino,et al.  Economics as a Factor in Models of Behavioral Motivation and Change , 2000, Substance use & misuse.

[5]  G. Madden,et al.  A comparison of measures of relative reinforcing efficacy and behavioral economics: cigarettes and money in smokers. , 1999, Behavioural pharmacology.

[6]  A. Öhman,et al.  Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme. , 1999, European heart journal.

[7]  P. Fioretti,et al.  Comprehensive cardiac rehabilitation: an issue to be readdressed. , 1999, European heart journal.

[8]  Colin Camerer Behavioral economics: reunifying psychology and economics. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A L Bretteville-Jensen,et al.  Addiction and discounting. , 1999, Journal of health economics.

[10]  M. Roizen,et al.  RealAge: Are You as Young as You Can Be? , 1999 .

[11]  A. Öhman,et al.  Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: a prospective, randomized controlled study. , 1999, Journal of psychosomatic research.

[12]  M. Roizen,et al.  Gains in life expectancy from medical interventions. , 1998, The New England journal of medicine.

[13]  A. Messori,et al.  Gains in life expectancy from medical interventions. , 1998, The New England journal of medicine.

[14]  L. Kimble Cognitive Appraisal and Cardiac Risk Reduction Behavior Following Coronary Angioplasty , 1998, Western journal of nursing research.

[15]  G. Marlatt,et al.  Consumer choice: Implications of behavioral economics for drug use and treatment , 1998 .

[16]  J. Allegrante,et al.  Can net-present value economic theory be used to explain and change health-related behaviors? , 1998 .

[17]  M C Weinstein,et al.  Gains in life expectancy from medical interventions--standardizing data on outcomes. , 1998, The New England journal of medicine.

[18]  M. Gulanick,et al.  Recovery patterns and lifestyle changes after coronary angioplasty: the patient's perspective. , 1998, Heart & lung : the journal of critical care.

[19]  J. Wright,et al.  Reducing the risk after coronary artery bypass surgery: documentation of risk factors and communication between hospital and general practice. , 1997, Public health.

[20]  E L Hannan,et al.  Coronary angioplasty volume-outcome relationships for hospitals and cardiologists. , 1997, JAMA.

[21]  D. Baim,et al.  Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. , 1996, Journal of the American College of Cardiology.

[22]  James T. Willerson,et al.  Appointment of New Associate Editor for Circulation , 1996 .

[23]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[24]  H. Barnhart,et al.  Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery. , 1996, Circulation.

[25]  J. Hirshfeld,et al.  Three-year clinical follow-up after Palmaz-Schatz stenting. , 1996, Journal of the American College of Cardiology.

[26]  H. Welch,et al.  Estimating Treatment Benefits for the Elderly: The Effect of Competing Risks , 1996, Annals of Internal Medicine.

[27]  K. McKenna,et al.  Coronary risk factor status after percutaneous transluminal coronary angioplasty. , 1995, Heart & lung : the journal of critical care.

[28]  W. Rogers,et al.  Bypass Angioplasty Revascularization Investigation (BARI): baseline clinical and angiographic data. , 1995, The American journal of cardiology.

[29]  C. Hamm,et al.  A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) , 1994, The New England journal of medicine.

[30]  M. Kutner,et al.  A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery , 1994 .

[31]  R. Krauss,et al.  Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). , 1994, Circulation.

[32]  I. Palacios,et al.  Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group. , 1993, Journal of the American College of Cardiology.

[33]  P. Hollman,et al.  CONTENT OF POTENTIALLY ANTICARCINOGENIC FLAVONOIDS OF TEA INFUSIONS, WINES, AND FRUIT JUICES , 1993 .

[34]  Joy,et al.  Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. , 1993, Lancet.

[35]  RITA-2 trial participants Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial , 1993, The Lancet.

[36]  Peter C. H. Hollman,et al.  Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands , 1992 .

[37]  J. Prochaska,et al.  In Search of How People Change: Applications to Addictive Behaviors , 1992, The American psychologist.

[38]  G. Schuler,et al.  Regular Physical Exercise and Low‐Fat Diet: Effects on Progression of Coronary Artery Disease , 1992, Circulation.

[39]  B. Lewis,et al.  Effects on Coronary Artery Disease of Lipid-Lowering Diet, or Diet Plus Cholestyramine, in the St. Thomasʼ Artherosclerosis Regression Study (STARS) , 1992 .

[40]  G. Watts,et al.  Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) , 1992, The Lancet.

[41]  B. Gaw Motivation to Change Life‐style Following PTCA , 1992, Dimensions of critical care nursing : DCCN.

[42]  L. Goldman,et al.  Expected Gains in Life Expectancy From Various Coronary Heart Disease Risk Factor Modifications , 1991, Circulation.

[43]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[44]  J P Matts,et al.  Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) , 1990, The New England journal of medicine.

[45]  Stotts Na,et al.  The effect of percutaneous transluminal coronary angioplasty on quality of life. , 1990 .

[46]  K. Gould,et al.  Lifestyle changes and heart disease , 1990, The Lancet.

[47]  J. Dartigues,et al.  Risk factors for progression of atherosclerosis six months after balloon angioplasty of coronary stenosis. , 1990, The American journal of cardiology.

[48]  R Brennecke,et al.  Analysis of risk factors for restenosis after PTCA. , 1990, Catheterization and cardiovascular diagnosis.

[49]  G. Beck,et al.  Risk factors for recurrent stenosis following successful coronary angioplasty. , 1989, Cleveland Clinic journal of medicine.

[50]  P. Nilsson-ehle,et al.  Improvements of the lipoprotein profile after coronary bypass surgery: additional effects of an exercise training program. , 1989, European heart journal.

[51]  V. L. Hanson Compliance with risk factor reduction among post-coronary-bypass surgery and post-coronary angioplasty patients. , 1988, Applied nursing research : ANR.

[52]  Kevin M. Murphy,et al.  A Theory of Rational Addiction , 1988, Journal of Political Economy.

[53]  V. Schoenbach,et al.  Health risk appraisal: review of evidence for effectiveness. , 1987, Health services research.

[54]  R. Califf,et al.  Medical approaches to prevention of restenosis after coronary angioplasty. , 1987, Journal of the American College of Cardiology.

[55]  B. Hedbäck,et al.  5-year results of a comprehensive rehabilitation programme after myocardial infarction. , 1987, European heart journal.

[56]  Galan Km,et al.  Recurrence of stenoses after coronary angioplasty. , 1986 .

[57]  I. Ajzen,et al.  Prediction of goal directed behaviour: Attitudes, intentions and perceived behavioural control , 1986 .

[58]  G. Fletcher Rehabilitation after coronary angioplasty--is it effective? , 1986, Archives of physical medicine and rehabilitation.

[59]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.

[60]  W L Beery,et al.  An assessment of health hazard/health risk appraisal. , 1982, American journal of public health.

[61]  I. Ajzen,et al.  Understanding Attitudes and Predicting Social Behavior , 1980 .

[62]  M. Becker,et al.  Health Belief Model and Personal Health Behavior , 1976 .

[63]  L. Robbins,et al.  Proposal for health-hazard appraisal in comprehensive health care. , 1968, JAMA.

[64]  I. Rosenstock Why people use health services. , 1966, The Milbank Memorial Fund quarterly.

[65]  R. Quandt,et al.  Measurement in Economics: Studies in Mathematical Economics and Econometrics in Memory of Yehuda Grunfeld. , 1963 .

[66]  R. Semple ILLUSTRATIONS OF CARDIAC DISEASE, DESIGNED TO SHOW THE PHYSICAL SIGNS AND POST-MORTEM APPEARANCES: OF THAT CLASS OF MALADIES; AND THE CONNECTION EXISTING BETWEEN THE MORBID CONDITIONS OF THE HEART AND OTHER ORGANS AND TISSUES OF THE BODY , 1843 .

[67]  K. Emmons,et al.  Motivational interviewing in health care settings. Opportunities and limitations. , 2001, American journal of preventive medicine.

[68]  T. Leonard,et al.  An economic theory of cigarette addiction. , 1999, Journal of health economics.

[69]  G. Laing,et al.  Risk factor reduction behaviours in coronary angioplasty and myocardial infarction patients. , 1994, Canadian journal of cardiovascular nursing = Journal canadien en soins infirmiers cardio-vasculaires.

[70]  M. Kutner,et al.  A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST) , 1994, The New England journal of medicine.

[71]  T. Couffinhal,et al.  Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty. , 1993, International journal of cardiology.

[72]  R. Arora,et al.  Restenosis after transluminal coronary angioplasty: a risk factor analysis. , 1990, Catheterization and cardiovascular diagnosis.

[73]  N. Lewis A dynamic theory of personality , 1935 .

[74]  D.,et al.  Regression Models and Life-Tables , 2022 .